๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

271 Trimodality treatment of surgically staged IIIA (N2) non-small cell lung cancer (NSCLC): Updated analysis of cancer and leukemia group B (CALGB) protocol 8935

โœ Scribed by Kumar, Parvesh; Herndon, J.; Sugarbaker, D.; Green, M.R.

Book ID
123217567
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
158 KB
Volume
18
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Patterns of disease failure after trimod
Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2): Analysis of Cancer and Leukemia Group B Protocol 8935
โœ Parvesh Kumar; James Herndon II; Mark Langer; Leslie J. Kohman; Anthony D. Elias ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 692 KB

The impact of sequential trimodality therapy on the pattern of first site disease failure in pathologic Stage IIIA (N2) nonsmall cell lung carcinoma (NSCLC) was analyzed. ## METHODS. Seventy-four eligible patients with histologically documented Stage IIIA (N2) NSCLC underwent sequential trimodali